ENXTPA:IPNPharmaceuticals
Ipsen (ENXTPA:IPN) Adds A Buy Back, Is The Stock Fully Priced?
Share buy-back adds to Ipsen news flow
Ipsen (ENXTPA:IPN) has added a share buy-back to its recent deal activity, repurchasing 11,795 shares between June 22 and June 26, 2026, at an average purchase price.
For investors tracking Ipsen stock, this small buy-back sits alongside the agreed €700 million acquisition of Memo Therapeutics and the earlier $1.75 billion Kartos Therapeutics deal, providing additional context to recent share performance.
See our latest analysis for Ipsen.
At a share...